SPECTRAL ANALYSIS OF NANO-PARTICLES OF TAXOL FOR INJECTABLE SUSPENSION

Authors

  • Mahendra Bhikonde
  • Dr. Abhishek Banke
  • Mrs. Shikha Singh
  • Dr. R.B. Goswami

Abstract

Aim In this formulation of Nano-particles to develop injectable suspension of Paclitaxel (Taxol).and paclitaxel nanoparticles prepared by precipitation techniques and the FTIR analysis and in vitro drug release, zeta potential and stability study were evaluated. Result that these studies provided conceptual proof that the nanoparticles size is (635-717nm) and the formulation PXN-6 were showed the good result for all the evaluation parameters.

Key words: Taxol, nanoparticles, Suspension, FTIR

References

Vyas SP, Khar RK Targeted & Controlled Drug Delivery Novel Carrier System. CBC Publication 2002; 6(2):249-227,331-387.

Majeti NV, Ravi Kumar A review of chitin and chitosan applications. Reactive and Functional Polymers 2000; 46(1):1-27.

Drug bank (17-03-2015,12:12:27PM) Paclitaxel available at http://www.drugbank.ca/drugs.(Acessed:3rd July 2017).

Indian Pharmacopoeia, Government of India. Ministry of Health and Family Welfare, Controller of publication, New Delhi.1996; 1: 423-424.

Teraj M, Sunil A. Novel interpenetrating network chitosan poly (ethylene oxide-g-acrylamide) hydrogel microspheres for the controlled release of capecitabine.

Donbrow M, Samuelov Y. Zero order drug delivery from double-layered porous films: Release rate profiles from ethyl cellulose, hydroxy propyl cellulose and polyethylene glycol mixtures. J Pharm Pharmacol. 1980; 32: 463-470.

Sandri. Chitosan-associated SLN in vitro and in vivo characterization of cyclosporine a loaded ophthalmic systems. J Microencapsul. 2010; 27: 735- 746.

Gadha A, Raina HF. Diazepam loaded solid lipid nanoparticles design and characterization.AAPSpharmaSci Tech. 2009; 10(1):221-19.

Downloads

Issue

Section

Original Research Article